The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase

Toxicology and Applied Pharmacology
Tzu-Chin WuShu-Lan Yeh

Abstract

Genistein has been shown to enhance the antitumor activity of trichostatin A (TSA) in human lung carcinoma A549 cells. However, whether the combined treatment exerts the same effect in other lung cancer cells is unclear. In the present study we first compared the enhancing effect of genistein on the antitumor effect of TSA in ABC-1, NCI-H460 (H460) and A549 cells. Second, we investigated whether the effects of genistein are associated with increased histone/non-histone protein acetylation. We found that the enhancing effect of genistein on cell-growth-arrest in ABC-1 cells (p53 mutant) was less than in A549 and H460 cells. Genistein enhanced TSA induced apoptosis in A549 and H460 cells rather than in ABC-1 cells. After silencing p53 expression in A549 and H460 cells, the enhancing effect of genistein was diminished. In addition, genistein increased TSA-induced histone H3/H4 acetylation in A549 and H460 cells. Genistein also increased p53 acetylation in H460 cells. The inhibitor of acetyltransferase, anacardic acid, diminished the enhancing effect of genistein on all TSA-induced histone/p53 acetylation and apoptosis. Genistein in combination with TSA increased the expression of p300 protein, an acetyltransferase, in A549 and NCI...Continue Reading

References

Jan 5, 2000·Oncogene·M Ashcroft, K H Vousden
Mar 8, 2003·The Journal of Biological Chemistry·Karanam BalasubramanyamTapas K Kundu
Dec 13, 2003·Cancer Letters·Krzysztof PolkowskiGrzegorz Grynkiewicz
Mar 30, 2004·Biochemical and Biophysical Research Communications·Tao HongTakashi Ito
Jul 30, 2005·Biochemical and Biophysical Research Communications·Peng WuDing Ma
Nov 26, 2005·Expert Opinion on Investigational Drugs·Paul A Marks, Milos Dokmanovic
Feb 14, 2006·The British Journal of Nutrition·Bertrand CaëtanoDominique J Bernard-Gallon
Oct 5, 2006·International Journal of Cancer. Journal International Du Cancer·Joshua P CantorKay Huebner
Jul 20, 2007·The Journal of Nutrition·Yoshie NagataHideyuki Akaza
Apr 24, 2008·International Journal of Cancer. Journal International Du Cancer·Nobuyuki KikunoRajvir Dahiya
May 20, 2008·Cell·Yi TangWei Gu
Jul 30, 2009·European Journal of Nutrition·Rong-Jen ShiauShu-Lan Yeh
Jun 10, 2011·Annals of Nutrition & Metabolism·G Sarwar GilaniGerard M Cooke
Jul 16, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Qian Li, Hong Chen
Jan 13, 2012·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·Pachaiappan PugalendhiNagarethinam Baskaran
Jan 12, 2013·Cellular and Molecular Life Sciences : CMLS·Feng WangMitsuhiko Ikura
Jun 12, 2013·Frontiers in Oncology·Stephen V LiuIte A Laird-Offringa
Sep 17, 2013·Cancer Chemotherapy and Pharmacology·Vasiliki PettaKonstantinos Syrigos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis